Zivo Bioscience, Inc. (ZIVO): Cost of Revenue
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$108.3K
Year ended 2024-12-31
$142.8K
Trailing 12 months to 2025-09-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $108.3K | +575.0% | 2025-03-18, From 2024-01-01 |
| 2023-12-31 | $16.0K | n/a | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2024-03-15, From 2022-01-01 |